Intas Pharmaceuticals Limited Rivaroxaban Export Data — India (DGFT 2022–2026)

Name: Intas Pharmaceuticals Limited Rivaroxaban Export Records India — #9 Exporter, 165 Shipments, $1.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Rivaroxaban

India Pharmaceutical Trade Intelligence

$52.6M221 Suppliers115 CountriesHS 30049099

ExportsIndia → NETHERLANDS29.9%India → MALTA9.6%

ImportsGERMANY → India$34.1B CANADA → India$46.0K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN IRELAND

Intas Pharmaceuticals Limited — Rivaroxaban Exporter #9 | $1.6M Trade Value | TransData Nexus | TransData Nexus

Intas Pharmaceuticals Limited — Rivaroxaban Exporter Profile

Indian Pharmaceutical Exporter · #9 for Rivaroxaban · $1.6M export value · DGFT Verified

Intas Pharmaceuticals Limited is the #9 Indian exporter of Rivaroxaban with $1.6M in export value and 165 verified shipments. Intas Pharmaceuticals Limited holds a 3.1% market share in Rivaroxaban exports across 13 countries. The company exports 75 pharmaceutical products worth $372.3M across 19 therapeutic categories.

Intas Pharmaceuticals Limited — Rivaroxaban Export Profile: Buyers & Destinations

Intas Pharmaceuticals Limited Rivaroxaban export treemap — buyers and destination countries | TransData Nexus

Where Does Intas Pharmaceuticals Limited Export Rivaroxaban?

Country	Value	Shipments	Share
CHILE	$514.2K	34	32.6%
POLAND	$275.6K	9	17.5%
MALTA	$199.1K	42	12.6%
UNITED KINGDOM	$196.7K	21	12.5%

Who Are the Top Buyers of Rivaroxaban from Intas Pharmaceuticals Limited?

Buyer	Country	Value	Orders
TO THE ORDER	CHILE	$801.5K	40
ACCORD UK	UNITED KINGDOM	$181.5K	18
PHARMADOX HEALTHCARE LTD	MALTA	$133.7K	37
ACCORD HEALTHCARE S.A.C	PERU	$114.0K	19
INSTITUTO SANITAS S.A.	CHILE	$64.8K	6
ITF-LABOMED FARMAC UTICA LIMITED	CHILE	$63.6K	2
ACCORD HEALTHCARE POLSKA SP. Z.O.O.	POLAND	$44.6K	2
TO THE ORDER.,	VENEZUELA	$40.9K	2
LABORATORIOS LA SANTE CIA LTDA	ECUADOR	$37.6K	3
BROCACEF NL : HUB	NETHERLANDS	$20.4K	20

Intas Pharmaceuticals Limited supplies Rivaroxaban to 20 buyers globally. The largest buyer is TO THE ORDER (CHILE), followed by ACCORD UK (UNITED KINGDOM) and PHARMADOX HEALTHCARE LTD (MALTA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Rivaroxaban Formulations Does Intas Pharmaceuticals Limited Export?

Product Description / Formulation	Value	Shipments
PHARM DRUG MED RIVAROXABAN 15MG 2X14T ACCORD PL EACH FILM COATED TABLET CONT RIVAROXABAN 15MGCOLOUR IRON O ASPERINV	$142.6K	3
PHARMA DRUG&MED: RIVAROXABAN 20MG 2X14T(ACCORD-UK EACH FILM COATED TABLET CONTAINS RIVAROXABAN.20 MG COLOUR: IRON OXIDE	$100.0K	2
PHARM DRUG&MED RILEX 20 2X14T EACH FILMCOATED TABLET CONT RIVAROXABAN 20 MG COLOURS: IRON OXIDE RED & TITANI (ASPERINV)	$87.1K	2
PHARM DRUG&MED:RIVAROXABAN 20MG 2X14T(ACCORD-PL)ACH FILM COATED TABLET CONT RIVAROXABAN 20 MG COLOUR: IRON (ASPERINV)	$72.8K	2
PHARM DRUG&MED RILEX 20 2X14T EACH FILMCOATED TABLET CONT:RIVAROXABAN 20MG COLOURS: IRON OXIDE RED & TITANIUM DIOXIDE	$64.8K	6
PHR DRUGS&MEDI RIVAROXABAN 20MG 10X10T(ACO-DK/NO/IS EACH FILM COATED TABLET CONTAINS RIVAROXABAN 20MG	$58.2K	3
PHARM DRUG&MED RIVAROXABAN 20MG 10X10T(ACO-DK/NO/IS EACH FILM COATED TABLET CONTRIVAROXABAN 20MG COLOUR IRON (ASPERINV)	$57.3K	2
PHARM DRUG&MED:TROMBEX RIVAROXABAN 20MG2X14TG1ITF-CHEACH FILM COA TAB CONT:RIVAROXABAN 20MG COLO:IRON OXIASPERINV	$50.0K	1
PH DRU MED XAROX RIVAROXABAN 15MG TABLETS EACH TABLET CONTAINS RIVAROXABAN15MG 1186 PACK X 3X10T	$50.0K	1
PHARMA DRUGS AND MEDI RIVATAS 10 3X10TABIMA(ZIM-MAT) RIVAROXABAN 10 MG AS PER INV	$47.4K	2

Intas Pharmaceuticals Limited exports 80 distinct Rivaroxaban formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PHARM DRUG MED RIVAROXABAN 15MG 2X14T ACCORD PL EACH FILM CO with 3 shipments worth $142.6K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Intas Pharmaceuticals Limited Compare to Nearest Rivaroxaban Exporters?

Exporters ranked immediately above and below #9 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
6	APOTEX RESEARCH PRIVATE LIMITED	$2.3M	54	1	$42.1K
7	TORRENT PHARMACEUTICALS LTD	$2.1M	59	5	$35.8K
9	INTAS PHARMACEUTICALS LIMITED ★	$1.6M	165	13	$9.9K
10	ALEMBIC PHARMACEUTICALS LIMITED	$1.3M	38	7	$33.5K
11	LUPIN LIMITED	$1.2M	28	3	$44.2K

Intas Pharmaceuticals Limited ranks #9 among 221 Indian Rivaroxaban exporters. Average shipment value of $9.9K compared to the market average of $166.0K. The closest competitors by value are APOTEX RESEARCH PRIVATE LIMITED and TORRENT PHARMACEUTICALS LTD.

Which Indian Ports Ship Rivaroxaban Exports?

Port	Shipments	% Share
SAHAR AIR	1,144	21.3%
DELHI AIR CARGO ACC (INDEL4)	985	18.4%
DELHI AIR	659	12.3%
SAHAR AIR CARGO ACC (INBOM4)	635	11.8%
Bombay Air	197	3.7%
NHAVA SHEVA SEA (INNSA1)	164	3.1%
Delhi Air	133	2.5%
HYDERABAD AIR	110	2.1%

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Rivaroxaban Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Intas Pharmaceuticals. The Israel-Iran tensions have led to increased security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and raised freight rates by 40–50% on key India–Europe routes, impacting the cost-effectiveness and timeliness of exports. (livemint.com)

Conversely, the ongoing US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture a larger share of the U.S. market. Intas's acquisition of UDENYCA® and the FDA's acceptance of its biosimilar applications position the company to leverage these opportunities effectively. However, compliance with the European Union's Falsified Medicines Directive (FMD) remains a critical factor for market access. Intas's proactive approach in securing partnerships and ensuring regulatory compliance underscores its commitment to maintaining and expanding its presence in the European market.

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

Maintaining stringent regulatory compliance is paramount for Indian pharmaceutical exporters. Intas Pharmaceuticals has demonstrated a strong commitment to adhering to international quality standards, as evidenced by its successful acquisitions and partnerships that necessitate compliance with FDA, WHO, and EU Good Manufacturing Practices (GMP). The company's proactive engagement in regulatory processes, such as the FDA's acceptance of its Biologics License Application for DMB-3115, reflects its dedication to quality and compliance. (intaspharma.com) As global regulatory requirements continue to evolve, Intas's focus on quality assurance and compliance positions it favorably in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Rivaroxaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Intas Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 165 individual customs records matching Intas Pharmaceuticals Limited exporting Rivaroxaban, covering 80 formulations to 13 countries via 20 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 115+ countries, 497+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Rivaroxaban

Rivaroxaban

Intas Pharmaceuticals Limited — Rivaroxaban Exporter Profile

Intas Pharmaceuticals Limited — Rivaroxaban Export Profile: Buyers & Destinations

Where Does Intas Pharmaceuticals Limited Export Rivaroxaban?

Who Are the Top Buyers of Rivaroxaban from Intas Pharmaceuticals Limited?

What Is India's Total Rivaroxaban Export Value and How Much Does Intas Pharmaceuticals Limited Contribute?

What Is the Average Shipment Value for Intas Pharmaceuticals Limited's Rivaroxaban Exports?

How Does Intas Pharmaceuticals Limited Compare to Other Indian Rivaroxaban Exporters?

What Rivaroxaban Formulations Does Intas Pharmaceuticals Limited Export?

How Does Intas Pharmaceuticals Limited Compare to Nearest Rivaroxaban Exporters?

Which Indian Ports Ship Rivaroxaban Exports?

Geopolitical & Trade Policy Impact on Intas Pharmaceuticals Limited's Rivaroxaban Exports

Intas Pharmaceuticals Limited — Regulatory Compliance & Quality Standards

About Intas Pharmaceuticals Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Rivaroxaban Export Data from Intas Pharmaceuticals Limited

Rivaroxaban Stats

Company Overview

Top Products by Intas Pharmaceuticals Limited

Related Analysis

Need Detailed Export Data?

Data Source